![Matthew Lang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lang
Direttore operativo presso
STRUCTURE THERAPEUTICS INC.
Patrimonio netto: 3 M $ in data 30/06/2026
Profilo
Mr. Matthew Lang is a Chief Operating Officer & General Counsel at Structure Therapeutics, Inc. Mr. Lang was previously employed as a Chief Legal Officer & Secretary by Metsera, Inc., a Secretary, Chief Legal & Business Officer by Lyell Immunopharma, Inc., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences Ltd., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences, Inc., a VP & Head- Global Litigation & Investigations by Gilead Sciences, Inc., an Attorney by Dechert LLP, and a Chairman-Management Board by Sumitomo Pharma Switzerland GmbH.
He also served on the board at United Way of the Bay Area.
He received his undergraduate degree from Queen's University and a graduate degree from The University of Pennsylvania Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2026 | 184.614 ( 0,13% ) | 3 M $ | 30/06/2026 |
Posizioni attive di Matthew Lang
| Società | Posizione | Inizio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Direttore operativo | 15/04/2026 |
Precedenti posizioni note di Matthew Lang
| Società | Posizione | Fine |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Consigliere Generale | 13/04/2025 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Direttore Amministrativo | 01/01/2023 |
United Way of the Bay Area
 United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Direttore/Membro del Consiglio | 01/01/2018 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2017 |
Formazione di Matthew Lang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
United Way of the Bay Area
United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Commercial Services |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
